<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DBDF7F01-F8AB-4EF4-B8E5-412693B7B86C"><gtr:id>DBDF7F01-F8AB-4EF4-B8E5-412693B7B86C</gtr:id><gtr:name>Philips Medical Systems UK Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1676980A-A1DB-42A0-B308-7F974A7010DF"><gtr:id>1676980A-A1DB-42A0-B308-7F974A7010DF</gtr:id><gtr:name>Synageva BioPharma Corp</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute for Ageing and Health</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBDF7F01-F8AB-4EF4-B8E5-412693B7B86C"><gtr:id>DBDF7F01-F8AB-4EF4-B8E5-412693B7B86C</gtr:id><gtr:name>Philips Medical Systems UK Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1676980A-A1DB-42A0-B308-7F974A7010DF"><gtr:id>1676980A-A1DB-42A0-B308-7F974A7010DF</gtr:id><gtr:name>Synageva BioPharma Corp</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1FD7D40F-3737-4E7A-BA28-F0FE54C74CBB"><gtr:id>1FD7D40F-3737-4E7A-BA28-F0FE54C74CBB</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Thelwall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801239"><gtr:id>851E6DDB-2125-4CA2-A21B-0A23FEF60BD2</gtr:id><gtr:title>In vivo monitoring of liver oxidative stress defences by magnetic resonance measurements of glutathione turnover</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801239</gtr:grantReference><gtr:abstractText>Liver disease is common, causing over 10,000 deaths in the UK per year. Liver disease often occurs as a gradual decline in liver health, with fatty liver, fibrosis and cirrhosis leading towards liver failure. Part of this decline involves ?oxidative stress?. This stress occurs when the liver is overwhelmed by damaging chemical species caused by drugs, alcohol, viral infection and the effects of having a fatty liver.
We are developing new ways of measuring the degree of oxidative stress in the liver, and of measuring how well the liver copes with this stress. We use MRI scanners to measure the liver?s production of glutathione, which is a natural antioxidant that the liver uses for protection against the chemicals that cause oxidative stress. This allows us to gauge the liver?s defence mechanisms in a non-invasive way, using an MRI scanner instead of taking a liver biopsy sample with a needle.
Our studies will characterise how liver glutathione synthesis rate changes when liver oxidative stress occurs, and demonstrates that these measurements can be made in people in a robust and safe manner. Thus we are developing new methods to monitor the role that oxidative stress plays in progression of liver disease. If successful, these methods may play a role in future liver disease research projects, and we hope to use these techniques to assess the impact of therapeutic strategies such as antioxidant supplementation treatments or diet and lifestyle changes.</gtr:abstractText><gtr:technicalSummary>Oxidative stress is central to the development and progression of liver disease. The overproduction of reactive oxygen species, and the inability of cells to defend against such insults, plays a central role in the development of fibrosis, hepatitis and cirrhosis. The main causes of oxidative stress are excess alcohol and viral infection, with iron overload, fatty liver and drugs also playing key roles.

Tissue damage occurs if cellular oxidative stress defences are overwhelmed. Glutathione (a tripeptide of cysteine, glycine and glutamate) serves as an antioxidant synthesised by cells, forming a central component of oxidative stress defence. Glutathione turnover reflects the strength of these defences, and is highly responsive to oxidative stress insults. We have developed non-invasive methods to measure glutathione turnover with magnetic resonance techniques. We propose to characterise the changes in liver glutathione synthesis and concentration in response to chronic and acute oxidative stress insults in animal models of liver disease, demonstrating the utility of glutathione turnover rate measurements as a gauge of tissue oxidative stress. We will also demonstrate that these methods can be translated to studies of human liver. 

Our methods measure glutathione turnover by introducing a non-radioactive isotope of carbon (13C) into the glutathione biosynthetic pathway. Studies on rats will compare treatment groups that represent normal, steatotic, acute injury (meditated by CCl4 insult), and combined steatotic/acute injury. Liver glutathione synthesis rate and concentration will be compared between treatment groups by MR spectroscopic imaging after infusion of [2-13C]-glycine. Analogous human studies will measure the rate of glutathione biosynthesis following ingestion of 13C-labelled glycine.

The proposed studies will provide a direct method of assessing liver oxidative stress without the need for invasive biospy sampling. We anticipate that development of these techniques and characterisation of response to insults will lead to studies of the real-time effects of antioxidant treatment, or stressors such as paracetamol and alcohol, on liver oxidative stress.</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-21</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-06-22</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>427468</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florida</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neuroscience</gtr:department><gtr:description>Steve Blackband</gtr:description><gtr:id>6966F289-B368-44BB-8FA3-66022835B487</gtr:id><gtr:impact>Publications:
- &amp;quot;Non-invasive Monitoring of L-2-Oxothiazolidine-4-carboxylate Metabolism in the Rat Brain by In vivo 13C Magnetic Resonance Spectroscopy&amp;quot;
- &amp;quot;In vivo magnetic resonance studies of glycine and glutathione metabolism in a rat mammary tumor&amp;quot;</gtr:impact><gtr:outcomeId>jkr5Nadgr3v-1</gtr:outcomeId><gtr:partnerContribution>Access to and expertise with high field MRI scanners.</gtr:partnerContribution><gtr:piContribution>Expertise on non-invasive measurements of tissue oxidative stress defences.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of North Carolina at Chapel Hill</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>UNC/NCSU Joint Department of Biomedical Engineering</gtr:department><gtr:description>Mike Gamcsik</gtr:description><gtr:id>F4462E02-55EC-4EDF-B4F3-77868691DDF7</gtr:id><gtr:impact>Publications:
- &amp;quot;Non-invasive Monitoring of L-2-Oxothiazolidine-4-carboxylate Metabolism in the Rat Brain by In vivo 13C Magnetic Resonance Spectroscopy&amp;quot;
- &amp;quot;In vivo magnetic resonance studies of glycine and glutathione metabolism in a rat mammary tumor&amp;quot;</gtr:impact><gtr:outcomeId>rfWM3G3vhaH-1</gtr:outcomeId><gtr:partnerContribution>Expertise in oxidative stress defences</gtr:partnerContribution><gtr:piContribution>Expertise in magnetic resonance spectroscopy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Nottingham University</gtr:description><gtr:id>42E87184-24D8-4EF6-9229-F3A9A7C8FFB1</gtr:id><gtr:impact>-</gtr:impact><gtr:outcomeId>58987dbad47762.99876161-1</gtr:outcomeId><gtr:partnerContribution>Design, performance and analysis of a healthy volunteer study of hepatic glutathione turnover rate.</gtr:partnerContribution><gtr:piContribution>Formed a collaborative project to develop measurement of glutathione turnover as a biomarker of liver oxidative stress defences.
We provided input into experimental design of a healthy volunteer study of liver glutathione turnover rate, and provided input into data analysis and interpretation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Edinburgh University - 13C MR spectroscopy</gtr:description><gtr:id>10E2CB9F-424B-41AC-8044-07E947E67279</gtr:id><gtr:impact>Provided MRI protocols and generated pilot MR data for an MRC grant application to be submitted by Edinburgh University.</gtr:impact><gtr:outcomeId>pofjNF4qB1n-1</gtr:outcomeId><gtr:partnerContribution>Edinburgh University project on brown adipose tissue metabolism.</gtr:partnerContribution><gtr:piContribution>Provided expertise on in vivo 13C MR spectroscopy methodology for a novel Edinburgh University project investigating brown adipose tissue metabolism.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Philips Medical Systems UK Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Philips</gtr:description><gtr:id>0FCA87AC-83CB-47B1-BF94-9375C376CB27</gtr:id><gtr:impact>Publications with the following DOIs:
10.1152/ajpendo.00376.2015
10.1042/CS20140681
10.1152/japplphysiol.01023.2015
10.1002/hep.26925</gtr:impact><gtr:outcomeId>58b041308fcbc7.85486212-1</gtr:outcomeId><gtr:partnerContribution>Provision of tools and technologies for development of human 13C spectroscopy measurements. These contributions include:
- access to and ability of modify MRI scanner source code to perform and optimise 13C MR spectroscopy
- ability to interface in-house and third party RF coils (MRI scanner sensors) to the MRI scanner</gtr:partnerContribution><gtr:piContribution>Information on MRI scanner technical requirements for development of successful human 13C spectroscopy methods.
Publication outputs describing development and application of human 13C spectroscopy methods.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Synageva BioPharma Corp</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Synageva Biopharma</gtr:description><gtr:id>DD521DA0-AC19-446D-8590-CBDE01EF21B9</gtr:id><gtr:impact>1) Publication: Pubmed ID = 23624251

2) Incorporation of novel MRI techniques as outcome measures in a phase 2 clinical trial.</gtr:impact><gtr:outcomeId>Her96EG4Dbz-1</gtr:outcomeId><gtr:partnerContribution>Provision of preclinical research materials for development of a novel non-invasive method to measure hepatic lipid composition.</gtr:partnerContribution><gtr:piContribution>Development and application of a novel non-invasive method to measure hepatic lipid composition and content via magnetic resonance spectroscopy.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Work experience for A-level physics students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DA97F54C-3C8D-4E54-87CE-3587A2D84281</gtr:id><gtr:impact>One student attended a 3 day work experience titled &amp;quot;Physics in Medical research: MRI&amp;quot;. The experience provided an insight into academic research and the practical application of physics in MRI scanning and medical research.

The work experience placement assisted the student degree course choice, and has decided to pursue a degree in physics.</gtr:impact><gtr:outcomeId>VqzggxXoFxt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Physics in medical research - talks to schoolchildren</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FE961976-E710-4420-B74F-B3E4A545308F</gtr:id><gtr:impact>Discussing the role of physics in biomedical research, and discussing research as a career option. Discussions took place with local A-level students visiting our research centre.

not known</gtr:impact><gtr:outcomeId>4F88ADBA773</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LiverNorth newsletter article (2013)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>73538231-EA71-413F-94D4-2689EE3C375D</gtr:id><gtr:impact>Article on &amp;quot;Using MRI in research into liver disease&amp;quot; published in the newsletter of &amp;quot;LiverNorth&amp;quot; - a support group for patients with liver disease (newsletter circulation = 2050).

No notable impacts to date.</gtr:impact><gtr:outcomeId>ErQtsxTkY3e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.livernorth.org.uk</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LiverNorth patient group discussion</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>445FE076-FC9F-4C0F-BAB0-346BB8565DAF</gtr:id><gtr:impact>20 patients with liver disease attended a meeting organised by the patient group &amp;quot;Liver North&amp;quot;. A presentation was made on how MRI is used in liver research, and was followed by questions and discussions.

Meeting organisers requested a written article on the use of MRI in research into liver disease for their newsletter, distributed to patients with liver disease in the NorthEast of England (circulation = 2050 copies).</gtr:impact><gtr:outcomeId>SSsYB2BdbkM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.livernorth.org.uk</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AASLD conference presentation (2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CA665E33-5AD8-4C8B-9C21-D77C0DB4528A</gtr:id><gtr:impact>Presentation at the American Association for the Study of Liver Diseases, Washington DC, 1st-5th November 2013.

Presentation details = &amp;quot;Magnetic Resonance Detection of Hepatic Cholesteryl Ester Accumulation for Non-invasive Identification and Treatment Monitoring in Lysosomal Acid Lipase Deficiency. P Thelwall, FE Smith, M Leavitt, W Hu, KG. Hollingsworth, C Thomas, M. Trenell, R Taylor, J Rutkowski, AM. Blamire, AG Quinn&amp;quot;

Discussions with clinical researchers regarding applications of characterising perturbed hepatic lipid metabolism.</gtr:impact><gtr:outcomeId>Czyfz7fRzsC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.aasld.org</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Performed first-in-man non-invasive measurement of hepatic glutathione synthesis rate by MRI methods, and demonstrated in preclinical studies that glutathione synthesis rate is a biomarker of cellular defences against oxidative stress in models of liver disease. Principle source of funding has been MRC grant G0801239.</gtr:description><gtr:id>FAB21477-1CB6-4ADE-9623-2C789D5B1756</gtr:id><gtr:impact>First demonstration of human feasibility of a novel biomarker for the study of liver disease. In addition, the development process led to creation of related methods to assess hepatic lipid composition in an inherited metabolic disorder, which will be used as an outcome measure in a clinical trial of a novel drug.</gtr:impact><gtr:outcomeId>DGUGJx9kJhB</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>Human hepatic glutathione synthesis rate measurement</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Developed protocol and hardware for acquisition of 13C magnetic resonance spectra from human liver for non-invasive assessment of hepatic lipid content and composition.</gtr:description><gtr:id>AF2611F3-3D39-49A0-94F8-089E69B63475</gtr:id><gtr:impact>Used to test determine liver lipid composition in patients with cholesterol ester storage disease.</gtr:impact><gtr:outcomeId>UQvEHZ89Tmc</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>13C spectroscopy protocol</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Method to quantify hepatic cholesterol ester content by non-invasive 1H magnetic resonance spectroscopy in patients with cholesterol ester storage disease.
Enables progression and treatment monitoring in this patient group using a repeatable, safe and non-invasive scan, instead of requiring liver biopsy.</gtr:description><gtr:id>ED7AAB2B-090A-43F6-BF7D-92751E143BEC</gtr:id><gtr:impact>Data analysis method to be employed in a clinical trial of a new enzyme replacement therapy treatment for cholesterol ester storage disease.</gtr:impact><gtr:outcomeId>LS4ov221Fxx</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hepatic lipid composition analysis method</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5C7E6E22-E2D9-4665-B4A8-0ECBEE301D84</gtr:id><gtr:title>Noninvasive in vivo magnetic resonance measures of glutathione synthesis in human and rat liver as an oxidative stress biomarker.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cb6e39a7d09a08328a53915ef602fcc"><gtr:id>8cb6e39a7d09a08328a53915ef602fcc</gtr:id><gtr:otherNames>Skamarauskas JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>YzCaJ4oQFbS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA01FDF2-2ABF-427C-B02C-2D36C46D92DC</gtr:id><gtr:title>Non-invasive monitoring of L-2-oxothiazolidine-4-carboxylate metabolism in the rat brain by in vivo 13C magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Neurochemical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d71af7764061820e686cef4144cc1e5"><gtr:id>0d71af7764061820e686cef4144cc1e5</gtr:id><gtr:otherNames>Gamcsik MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-3190</gtr:issn><gtr:outcomeId>MCMQ2VEKQgq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F944BDD2-70F4-4421-B911-B41F81202C64</gtr:id><gtr:title>Sucrose ingestion after exhaustive exercise accelerates liver, but not muscle glycogen repletion compared with glucose ingestion in trained athletes.</gtr:title><gtr:parentPublicationTitle>Journal of applied physiology (Bethesda, Md. : 1985)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92d8f6b1c914e2dc1292aa73a0a3fc2e"><gtr:id>92d8f6b1c914e2dc1292aa73a0a3fc2e</gtr:id><gtr:otherNames>Fuchs CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0161-7567</gtr:issn><gtr:outcomeId>58987f5d926459.58110230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3F5A87F-CE13-41B8-B583-95627FEB47C1</gtr:id><gtr:title>Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bd786794a7beca0f215d6892dc90419"><gtr:id>3bd786794a7beca0f215d6892dc90419</gtr:id><gtr:otherNames>Thelwall PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>pm_12493_23_23624251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C73F6906-40F6-4F0C-AE06-AB04E4B792B7</gtr:id><gtr:title>Ingestion of glucose or sucrose prevents liver but not muscle glycogen depletion during prolonged endurance-type exercise in trained cyclists.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baeaada2e53a73ff7e20f630248e399d"><gtr:id>baeaada2e53a73ff7e20f630248e399d</gtr:id><gtr:otherNames>Gonzalez JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>58987f5db6e339.24792545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD66B961-DD50-4B0E-B8EE-069854C3EAE5</gtr:id><gtr:title>In vivo MR studies of glycine and glutathione metabolism in a rat mammary tumor.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bd786794a7beca0f215d6892dc90419"><gtr:id>3bd786794a7beca0f215d6892dc90419</gtr:id><gtr:otherNames>Thelwall PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>o515bUFQjjH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93D9E173-538B-4B70-86DB-ADD24B05764E</gtr:id><gtr:title>Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type&amp;nbsp;2 diabetes.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31542030c1ce5055b312d9e4e5efb600"><gtr:id>31542030c1ce5055b312d9e4e5efb600</gtr:id><gtr:otherNames>Macauley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>58987f5ddd9e37.15243616</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801239</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>